Acta Materia Medica (@AMM_journal) header
Acta Materia Medica (@AMM_journal) profile picture

An open platform for rapid publication of the latest pharmaceutical science research. Bluesky - https://teapaw.org/t.co/rkG5gUqXjz

Shannon, Ireland
Joined November 2021
Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)
Exploring advances in Cancer Therapeutics, Targets & Resistance from Acta Materia Medica Discover cutting-edge research: amm-journal.org/ #CancerResearch #CancerTherapeutics #DrugResistance #Oncology
7
2
1
687
Acta Materia Medica retweeted
Postdoc in Medicinal Chemistry of Host-Targeting Anti-Viral Agents at DTU Chemistry, Denmark Technical University of Denmark (DTU) Chemistry is seeking a talented and motivated postdoc to drive the search for new anti-viral agents, specifically focused researchersjob.com/postdoc-i…
1
1
80
Acta Materia Medica retweeted
TODAY IS THE LAST DAY FOR ABSTRACT SUBMISSION! Join the 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy. Date: December 08–09, 2026 Kuala Lumpur, Malaysia Submit Your Abstract: pharmacy.ucgconferences.com/… WhatsApp: +971551792927
🤖 Made with AI
1
1
15
Acta Materia Medica retweeted
Replying to @Bayer
@Bayer Foundation Fellowship scientific fellowships for outstanding master, PhD, and medical students to pursue international research projects, internships in Agriculture, Medical, Climate & Health and Drug Discovery Details at bayer-foundation.com/en/scie… Apply by 18th January 2027
3
11
715
A Caryota maxima extract extended lifespan in C. elegans through DAF-2 signaling and MUFA-dependent metabolic regulation, with rutin reproducing key geroprotective effects. #Geroscience #Celegans #AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
1
1
32
Acta Materia Medica retweeted
Submit your nomination for the following Lectureships and Awards by Tuesday, 1 December: 🌟 Philip S. Portoghese Medicinal Chemistry Lectureship 🌟 ACS Infectious Diseases Early Career Award 🌟 ACS Synthetic Biology Early Career Innovator Award go.acs.org/eYd
1
2
510
Acta Materia Medica retweeted
📢 FULLY FUNDED 4-YEAR PHD POSITION IN MEDICINAL CHEMISTRY AND CHEMICAL BIOLOGY (START 2027) 
🔬 Project: Chemically induced proximity for targeted therapies against cancer and progeria, using chemical proteomics, E3 ligase validation, and PROTAC development 
🧑‍🎓 Universidad Complutense de Madrid, Spain 
🥼 Medicinal Chemistry Laboratory (Prof. Silvia Ortega Gutiérrez), Department of Organic Chemistry 
🚨 Requirements: Bachelor's and Master's degrees in chemistry (300 credits total). Strong foundation in organic chemistry, synthesis, and structural elucidation. 
📅 Deadline: 4 December 2026 
🚨 Apply now: send CV with transcripts and two references' contact details to [email protected], and apply via the UCM online platform
1
2
520
Acta Materia Medica retweeted
A #pharmacogenomics analysis of 100,000 participants in the @AllofUsResearch program sheds light on the landscape of pharmacogene variants in diverse ancestries and tackles gaps in genomics knowledge in underrepresented groups. @ScienceTM scim.ag/3UJEKUL
1
3
12
13,068
Acta Materia Medica retweeted
This review examines how androgen receptor alterations contribute to CRPC and discusses PROTACs as tools for degrading proteins that sustain disease progression and therapeutic resistance. #CancerBiology #ProstateCancer @harvardmed #AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
1
2
2
41
Acta Materia Medica retweeted
A randomized trial found that Cs4 improved symptom severity, fatigue, insomnia, respiratory symptoms, and quality of life over 12 weeks in patients with long COVID. #ClinicalTrials #CordycepsSinensis @HKUniversity #AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
1
2
2
40
Acta Materia Medica retweeted
💊 Not every disease-associated molecular change is a promising drug target. In @DrugTargetRev , our Dr Shi-qi An explores how multiomics, single-cell and spatial technologies can strengthen drug target discovery. 🔗 drugtargetreview.com/home/ho…
1
1
62
Acta Materia Medica retweeted
Be Part of the Future of Pharmacology Join PHARMAUE 2026 – 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy. Date: 8–9 December 2026 Venue: Kuala Lumpur, Malaysia & Virtual Register Now: pharmacy.ucgconferences.com/…
1
1
39
This review highlights microneedles as a user-friendly strategy for enhancing transdermal insulin transport while overcoming gastrointestinal and skin barriers. #Pharmaceutics #DrugDelivery #AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
2
31
Acta Materia Medica retweeted
Join us at these upcoming conferences: - Drug Discovery Chemistry Europe, November 10-12, Barcelona, Spain drugdiscoverychemistry.com/e… - The 43rd Medicinal Chemistry Symposium, November 11-13, Kyoto, Japan k-gakkai.jp/mcs2026/en/en_in… We will be happy to meet you, discuss the latest developments in Drug Discovery, and explore new opportunities for collaboration.
1
2
406
Acta Materia Medica retweeted
🇳🇱 Leiden University — PhD in AI-Driven Drug Discovery 🔥 URGENT | MSCA-Funded | Deadline: November 12, 2026 🏫 University: Leiden University 🔬 Laboratory: Leiden Academic Centre for Drug Research (LACDR) — Computational Drug Discovery Group 📍 Location: Leiden, Netherlands 🆕 Published: October 15, 2026 📖 Research Project: ANA-KIN DC10 — Deep Learning for Kinase Drug Discovery This PhD focuses on developing artificial intelligence models to discover new cancer therapeutics targeting protein kinases. Unlike conventional kinase inhibitors, which primarily target ATP-binding sites, the project investigates alternative regulatory interfaces to improve drug selectivity and overcome resistance. Research Activities: •Develop deep-learning models for kinase inhibitor discovery. •Integrate chemical, structural, and biophysical datasets. •Predict molecular binding and drug-resistance mechanisms. •Design computational approaches for peptide-based therapeutics. •Apply AI models to experimental drug-discovery workflows. •Develop open-source computational tools. The position includes research secondments at two Belgian partner organizations. 💰 Funding Details: ✅ Fully funded through the Horizon Europe MSCA Doctoral Network ANA-KIN. ✅ Four-year salaried PhD position. ✅ Gross monthly salary: €3,204–€4,051. ✅ Additional 8% holiday allowance. ✅ Additional 8.3% year-end allowance. ✅ University pension and employment benefits. ✅ International research secondments and specialist training. Contract Structure: Initial one-year appointment, extendable for the remaining three years after a positive evaluation. 🔍 Application Requirements: •Master’s degree in Computer Science, AI, Computational Chemistry, Bioinformatics, or a related field. •Experience with machine learning and deep learning, preferably PyTorch. •Knowledge of cheminformatics or computational chemistry. •Excellent Python programming skills. •Strong academic English. •Interest in pharmaceutical research. MSCA Eligibility: •Applicants must not already hold a doctoral degree. •Applicants must not have lived, worked, or studied in the Netherlands for more than 12 months during the preceding 36 months, subject to MSCA exceptions. Required Documents: •Motivation letter confirming MSCA eligibility. •Academic CV. •Academic grade list. •Contact details of two referees. 🕒 Application Deadline: November 12, 2026. ⏳ Time Remaining: 4 Days! ⭐ Why Apply? This is an excellent opportunity to combine artificial intelligence with pharmaceutical research. The project offers a competitive Dutch salary, international research experience, and collaboration with academic and industrial partners. 🔗 Official University Application: careers.universiteitleiden.n… #phd #PhD #phdopportunity #phdposition
1
2
80
Acta Materia Medica retweeted
POSTDOCTORAL FELLOWSHIPS IN MEDICINAL CHEMISTRY AT UNIVERSITY OF CAPE TOWN 👇👇👇👇👇👇👇👇 @PostdocPhd @PostdocO
3
1
1
81